Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study

Table 1 Characteristics in the trans-perineal (TP) and trans-rectal prostate (TR) biopsy

	TP(n = 130)	TR(n = 108)	P value
Age (years)	66.6 ± 8.81	67.1 ± 8.45	0.708^b
Median PSA level (ng/ml) [25–75%]	9.3[6.3–20.3]	10.9[7.8–17]	0.099^a
PSA < 4 ng/ml	3/130	7/108	0.11^c
10 > PSA > 4 ng/ml	62/130	52/108	0.944^c
PSA > 10 ng/ml	66/130	49/108	0.407^c
DRE positive	49/130	50/108	0.18^c
Median Biopsy core number [25–75%]	10[10–10]	10[10–10]	0.574^a
Prostate Volume [25–75%]	32.5[27–41]	35[29–47]	0.015^a
Prophylaxis abx use	0/130	Baktar: 28/108 Ceftibuten:25/108 Ciprofloxacin:5/108 Levofloxacin:50/108	<0.001^c
Anesthesia procedure	IVG: 32/130 LA + PPNB: 98/130	Lidocaine Jelly lubrication

TP trans-perineal prostate biopsy, TR trans-rectal prostate biopsy, PSA prostate specific antigen, DRE digital rectal examination, ^a: Mann-Whitney test. ^b: Student T test. ^c: Chi-Square test

ISSN: 1471-2490